New hope for high altitude emergencies: study tests Life-Saving treatments
NCT ID NCT07639931
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to improve treatment for severe high altitude pulmonary edema (fluid in the lungs) and cerebral edema (brain swelling). Researchers will test breathing support devices and inhaled nitric oxide gas in over 3,000 patients in Tibet. The goal is to speed up recovery, reduce hospital stays, and prevent deaths.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- inhaled nitric oxide
- What this could lead to
- If successful, this could establish standard treatments for severe high altitude sickness, reducing deaths and improving recovery in mountainous regions.
- What could go wrong
- This trial is not yet recruiting and is early-stage. The treatments may not prove effective for all patients, and side effects from nitric oxide or breathing devices are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE HIGH ALTITUDE CEREBRAL EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xizang Autonomous Region People's Hospital
Lhasa, Tibet, 850000, China